Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × Myofibroma × Clear all

Phase

Phase NA 24 Phase 3 10 Phase 4 4 Phase 1 3 Phase 2 2 Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 87 Prostatic Neoplasms 37 Neoplasms 35 Glioblastoma 23 Head and Neck Neoplasms 22 Melanoma 20 Brain Neoplasms 19 Carcinoma, Hepatocellular 17 Squamous Cell Carcinoma of Head and Neck 15 Ovarian Neoplasms 15 Carcinoma, Renal Cell 15 Pancreatic Neoplasms 13 Lung Neoplasms 13 Leukemia, Myeloid, Acute 13 Colorectal Neoplasms 13 Glioma 12 Carcinoma, Non-Small-Cell Lung 11 Urinary Bladder Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Polycystic Ovary Syndrome 9 Lymphoma 9 Myelodysplastic Syndromes 8 Multiple Myeloma 8 Endometrial Neoplasms 8 Uterine Cervical Neoplasms 7 Lymphoma, Mantle-Cell 7 Lymphoma, Large B-Cell, Diffuse 7 Triple Negative Breast Neoplasms 6 Neoplasms, Plasma Cell 6 Neoplasm Metastasis 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06959966 2025-05-07

Effects of Oligo-fucoidan on Leiomyoma Patients

Taipei Medical University

Phase EARLY_PHASE1 Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡